Indoco Remedies (Indoco) is a Mumbai-based pharmaceutical company that focuses on formulations with a presence in contract manufacturing and research. The Company is engaged in the manufacturing and marketing of pharmaceutical Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).
Financial Results:
- Indoco Remedies Ltd reported Revenues for Q1FY24 of ₹426.00 Crores up from ₹408.00 Crore year on year, a rise of 4.41%.
- Total Expenses for Q1FY24 of ₹393.00 Crores up from ₹361.00 Crores year on year, a rise of 8.86%.
- Consolidated Net Profit of ₹24.00 Crores down 38.46% from ₹39.00 Crores in the same quarter of the previous year.
- The Earnings per Share is ₹2.65, down 36.75% from ₹4.19 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.